 
    Align Technology, Inc. is a prominent player in the medical devices market, primarily known for its innovative Invisalign clear aligners and iTero intraoral scanners. Operating globally, the company has showcased consistent growth in its orthodontic and digital dentistry markets. As of now, ALGN exhibits a balanced performance, indicating promising yet cautious potential for investors.
The fundamental analysis of Align Technology, Inc. indicates a stable financial health with room for improvement in valuation metrics.
| Category | Score | Visualization | 
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 3 | |
| Price to Earnings | 2 | |
| Price to Book | 2 | 
Analyzing the historical ratings allows for comparing current and past performance metrics.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B | 
|---|---|---|---|---|---|---|---|
| 2025-07-18 | 3 | 4 | 4 | 4 | 3 | 2 | 2 | 
| Previous | 0 | 4 | 4 | 4 | 3 | 2 | 2 | 
The analyst price targets suggest a broad range for ALGN, highlighting potential market volatility.
| High | Low | Median | Consensus | 
|---|---|---|---|
| 790 | 225 | 300 | 421 | 
 
The analyst sentiment is predominantly bullish, with a significant number of buy recommendations.
| Recommendation | Count | Visualization | 
|---|---|---|
| Buy | 24 | |
| Hold | 7 | |
| Sell | 2 | 
Overall, Align Technology, Inc. presents a compelling investment opportunity, provided its innovative offerings and market leadership in clear aligners and intraoral scanners. Although the financial ratings suggest room for improvement, particularly in valuation metrics, the positive analyst sentiment and strong market presence offer favorable growth prospects. Investors should consider potential risks associated with price fluctuations and competitive pressures in the medical device sector. A long-term perspective may yield significant returns as ALGN continues to innovate.